Insider · CIK 0001845711

Apeiron Investment Group Ltd.

CIK 0001845711 Name as filed on the most recent filing

Filed as Apeiron Investment Group Ltd. (19)

31 transaction lines · from 19 filings · filed 2021-06-24 to 2026-08-20 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-19 P, Open-market purchase Enhanced Group Inc.ENHA 2 lines 2,778,446, acquired Open Form 4 filing 0001193125-26-357979
2026-08-18 P, Open-market purchase Enhanced Group Inc.ENHA 158,212, acquired Open Form 4 filing 0001193125-26-357979
2026-08-17 P, Open-market purchase Enhanced Group Inc.ENHA 330,420, acquired Open Form 4 filing 0001193125-26-354788
2026-08-14 P, Open-market purchase Enhanced Group Inc.ENHA 295,620, acquired Open Form 4 filing 0001193125-26-353161
2025-08-14 P, Open-market purchase Atai Life Sciences N.V.ATAI 19,000,000, acquired Open Form 4 filing 0000950170-25-109858
2025-03-24 P, Open-market purchase Atai Life Sciences N.V.ATAI 2,520,000, acquired Open Form 4 filing 0000950170-25-043942
2025-02-14 P, Open-market purchase Atai Life Sciences N.V.ATAI 22,755,008, acquired Open Form 4 filing 0000950170-25-023436
2024-10-04 S, Open-market sale Bionomics Ltd/ADRBNOX 156, disposed Open Form 4 filing 0000950170-24-113344
2024-10-03 S, Open-market sale Bionomics Ltd/ADRBNOX 52,405, disposed Open Form 4 filing 0000950170-24-113344
2024-10-02 S, Open-market sale Bionomics Ltd/ADRBNOX 29,966, disposed Open Form 4 filing 0000950170-24-113344
2023-06-01 S, Open-market sale Sensei Biotherapeutics, Inc.SNSE 2 lines 5,437,824, disposed Open Form 4 filing 0000921895-23-001420
2023-03-29 P, Open-market purchase Atai Life Sciences N.V.ATAI 1,600,443, acquired Open Form 4 filing 0000899243-23-009973
2023-02-23 P, Open-market purchase Sensei Biotherapeutics, Inc.SNSE 2 lines 3,539, acquired Open Form 4 filing 0000921895-23-000615
2022-04-29 P, Open-market purchase Atai Life Sciences N.V.ATAI 97,801, acquired Open Form 4 filing 0000899243-22-016117
2022-04-28 P, Open-market purchase Atai Life Sciences N.V.ATAI 154,689, acquired Open Form 4 filing 0000899243-22-016117
2022-04-27 P, Open-market purchase Atai Life Sciences N.V.ATAI 91,939, acquired Open Form 4 filing 0000899243-22-015852
2022-04-26 P, Open-market purchase Atai Life Sciences N.V.ATAI 216,628, acquired Open Form 4 filing 0000899243-22-015852
2022-04-25 P, Open-market purchase Atai Life Sciences N.V.ATAI 42,843, acquired Open Form 4 filing 0000899243-22-015653
2022-04-22 P, Open-market purchase Atai Life Sciences N.V.ATAI 254,962, acquired Open Form 4 filing 0000899243-22-015653
2022-04-21 P, Open-market purchase Atai Life Sciences N.V.ATAI 340,040, acquired Open Form 4 filing 0000899243-22-016301
2022-04-20 P, Open-market purchase Atai Life Sciences N.V.ATAI 344,513, acquired Open Form 4 filing 0000899243-22-016301
2022-04-19 P, Open-market purchase Atai Life Sciences N.V.ATAI 334,739, acquired Open Form 4 filing 0000899243-22-015168
2022-04-18 P, Open-market purchase Atai Life Sciences N.V.ATAI 277,656, acquired Open Form 4 filing 0000899243-22-015168
2022-04-14 P, Open-market purchase Atai Life Sciences N.V.ATAI 25,779, acquired Open Form 4 filing 0000899243-22-014963
2022-04-12 P, Open-market purchase Atai Life Sciences N.V.ATAI 269,560, acquired Open Form 4 filing 0000899243-22-014797
2022-04-11 P, Open-market purchase Atai Life Sciences N.V.ATAI 260,554, acquired Open Form 4 filing 0000899243-22-014575
2022-04-08 P, Open-market purchase Atai Life Sciences N.V.ATAI 277,640, acquired Open Form 4 filing 0000899243-22-014575
2021-06-22 P, Open-market purchase Atai Life Sciences N.V.ATAI 10,500,000, acquired Open Form 4 filing 0000899243-21-025738

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Apeiron Investment Group Ltd., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001845711

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.